Scientist holding a piece of Skelte up to the light
Search Symbol
Plus symbol to reveal more information.
Search Symbol
Plus symbol to reveal more information.

The most advanced bioprocesses, biomaterials and bioreactors for regenerative medicine.

Octane powers transformative healthcare.




We innovate game changing medical technologies.

We advance innovations into production within market-specific ventures.

We build partnerships for global commercialization.





Cocoon Production Systems for Cell Therapy

learn more


Tissue Engineering for Orthopedic Repair

learn more


Radioisotope delivery systems for RUBY-FILL

learn more

our innovations

Game-changing bioprocesses, biomaterials and bioreactors for regenerative medicine.



Market-specific Octane companies empowered to develop and launch our latest innovations.



Collaborations with global leaders to bring our medical technology solutions to the world.


Regenerative medicine as the standard of care

Our body’s natural processes and materials are highly efficient at repairing damage and restoring normal function. Octane innovations work at the cellular level to harness and accelerate these inherent healing abilities, with the goal of achieving sustained therapeutic benefits that surpass conventional therapies.

It’s regenerative medicine at its best. Together with our partners, we’re working at the highest levels of creativity to develop, manufacture and commercialize the most advanced bioprocesses, biomaterials and bioreactors. Our goal: to make regenerative medicine the new standard of care.

Recent News

March 2, 2022

Octane HyperPEEK® offers breakthrough biocomposite for enhanced bone regeneration

Kingston, Ontario, June 2, 2022 – Octane Exo Inc., an Octane Medical Group venture, has achieved a breakthrough in medical implant technology with Octane HyperPEEK, an advanced biocomposite proven to enhance bone regeneration with the goal of enhanced integration and stability.

read more

December 15, 2020

Octane Completes Major Expansion of State-of-the-Art Facility in Kingston, Ontario

Kingston, Ontario, 15 December 2020 – Octane Medical Group has expanded its state-of-the-art facility in Kingston, Ontario Canada. The 40,000-square-foot building, which Octane purchased in 2011, houses the company's head office and features regulated biolabs for biomaterial and biologics discovery programs including cell therapy research and development, a ...

read more

March 18, 2020

Octane Wins 2020 Edison Award in Cellular Research for AUTOGRAFTA™ Synthesis of Living Grafts for Skeletal Reconstruction

Maine, USA, 18 March 2020 – Octane innovations in tissue engineering, personalized medicine and automated living implant production have earned one of the highest Edison Awards, winning Gold in the Medical / Dental Cellular Research category. The Gold award recognizes AUTOGRAFTA™ living graft technology and the ability to ...

read more

October 29, 2018

Lonza Acquires a Controlling Stake in Octane Biotech to Further Develop Cocoon™ Autologous Technology

Basel, Switzerland, 29 October 2018 – Lonza announced today the acquisition of a controlling stake in Octane Biotech, with the right to acquire full ownership. The increase in equity share will allow Lonza to further develop the technology to support the growing need for scalable autologous manufacturing. Octane ...

read more

You’re a Game Changer – So Are We

With our game-changing bioengineering innovations, we’re transforming the delivery of regenerative medicine solutions, creating market-leading business opportunities for our ventures, and empowering our global network of commercial partners.